A RIG-I inhibitor
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

RIG012

Item No. 46473

Technical Information
Formal Name
3,3-diethyl-4-(phenylmethoxy)-2H-benz[g]indole-2,5(3H)-dione
CAS Number
2642218-43-5
Molecular Formula
C23H21NO3
Formula Weight
Purity
≥98%
A solid
DMSO: Soluble: ≥ 10 mg/mlEthanol: Sparingly soluble: 1-10 mg/ml
SMILES
CCC1(C(C2=NC1=O)=C(C(C3=C2C=CC=C3)=O)OCC4=CC=CC=C4)CC
InChi Code
InChI=1S/C23H21NO3/c1-3-23(4-2)18-19(24-22(23)26)16-12-8-9-13-17(16)20(25)21(18)27-14-15-10-6-5-7-11-15/h5-13H,3-4,14H2,1-2H3
InChi Key
OEWZCENSPLZNPQ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    RIG012 is an inhibitor of retinoic acid-inducible gene 1 (RIG-I; IC50 = 0.71 µM for the ATPase activity).1 It completely inhibits RIG-I-agonist-induced increases in IFN-β and radical S-adenosylmethionine domain-containing protein 2 (RSAD2) levels in A549 cells at 9 µM and reduces alendronate- and lipid A-induced IFN-β production in J774.1 macrophages at 5 µM.1,2 RIG012 (5 mg/kg) decreases lung injury scores and increases survival in a mouse model of pneumonia induced by K. pneumoniae.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Rawling, D.C., Jagdmann, G.E., Jr., Potapova, O., et al. Small-molecule antagonists of the RIG-I innate immune receptor. ACS Chem. Biol. 15(2), 311-317 (2020).

    2. Watanabe, S., Kiyoura, Y., and Tamai, R. Pretreatment with alendronate augments lipid A-induced IFN-β production via upregulation of cGAS expression. Pharmacol. Rep. 77(5), 1389-1399 (2025).

    3. Zhang, S., Chen, H., Xie, J., et al. RIG012 assists in the treatment of pneumonia by inhibiting the RIG-I-like receptor signaling pathway. Front. Med. (Lausanne) 11:1501761, (2024).